| Acinetobacter baumannii |
Acinetobacter baumannii |
Inhibition |
9.65 |
% |
10.6019/CHEMBL4513149 |
| Acinetobacter baumannii |
Acinetobacter baumannii |
MIC |
10000.0 |
nM |
10.6019/CHEMBL4513141 |
| Acinetobacter baumannii |
Acinetobacter baumannii |
MIC |
20000.0 |
nM |
10.6019/CHEMBL4513161 |
| Actinomyces viscosus |
Actinomyces viscosus |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Actinomyces viscosus |
Actinomyces viscosus |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Actinomyces viscosus |
Actinomyces viscosus |
MIC90 |
32.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Anaerococcus prevotii |
Anaerococcus prevotii |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Anaerococcus prevotii |
Anaerococcus prevotii |
MIC50 |
0.5 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Anaerococcus prevotii |
Anaerococcus prevotii |
MIC90 |
1.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Anaerococcus tetradius |
Anaerococcus tetradius |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Anaerococcus tetradius |
Anaerococcus tetradius |
MIC50 |
0.5 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Anaerococcus tetradius |
Anaerococcus tetradius |
MIC90 |
1.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bacillus anthracis |
Anthrax lethal factor |
Potency |
1258.9 |
nM |
None |
| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
50118.7 |
nM |
None |
| Bacteroides caccae |
Bacteroides caccae |
MIC |
0.5 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bacteroides caccae |
Bacteroides caccae |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bacteroides caccae |
Bacteroides caccae |
MIC90 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bacteroides fragilis |
Bacteroides fragilis |
MIC |
2.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bacteroides fragilis |
Bacteroides fragilis |
MIC50 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bacteroides fragilis |
Bacteroides fragilis |
MIC90 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bacteroides ovatus |
Bacteroides ovatus |
MIC |
1.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bacteroides ovatus |
Bacteroides ovatus |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bacteroides ovatus |
Bacteroides ovatus |
MIC90 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bacteroides stercoris |
Bacteroides stercoris |
MIC |
1.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bacteroides stercoris |
Bacteroides stercoris |
MIC50 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bacteroides stercoris |
Bacteroides stercoris |
MIC90 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bacteroides thetaiotaomicron |
Bacteroides thetaiotaomicron |
MIC |
1.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bacteroides thetaiotaomicron |
Bacteroides thetaiotaomicron |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bacteroides thetaiotaomicron |
Bacteroides thetaiotaomicron |
MIC90 |
8.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bacteroides uniformis |
Bacteroides uniformis |
MIC |
1.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bacteroides uniformis |
Bacteroides uniformis |
MIC50 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bacteroides uniformis |
Bacteroides uniformis |
MIC90 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bifidobacterium bifidum |
Bifidobacterium bifidum |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bifidobacterium bifidum |
Bifidobacterium bifidum |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bifidobacterium bifidum |
Bifidobacterium bifidum |
MIC90 |
32.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bifidobacterium breve |
Bifidobacterium breve |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bifidobacterium breve |
Bifidobacterium breve |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bifidobacterium breve |
Bifidobacterium breve |
MIC90 |
32.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bifidobacterium longum |
Bifidobacterium longum |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bifidobacterium longum |
Bifidobacterium longum |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Bifidobacterium longum |
Bifidobacterium longum |
MIC90 |
32.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Campylobacter jejuni |
Campylobacter jejuni |
MIC |
800.0 |
nM |
10.1016/j.bmcl.2010.04.126 |
| Campylobacter jejuni subsp. jejuni |
Pyruvate-flavodoxin oxidoreductase |
Activity |
20.0 |
nmol/mg/min |
10.1128/aac.01159-06 |
| Campylobacter jejuni subsp. jejuni |
Pyruvate-flavodoxin oxidoreductase |
Ki |
10500.0 |
nM |
10.1128/aac.01159-06 |
| Candida albicans |
Candida albicans |
Inhibition |
26.69 |
% |
10.6019/CHEMBL4513149 |
| Candida albicans |
Candida albicans |
MIC |
10000.0 |
nM |
10.6019/CHEMBL4513141 |
| Candida albicans |
Candida albicans |
MIC |
20000.0 |
nM |
10.6019/CHEMBL4513161 |
| Chikungunya virus |
Chikungunya virus |
EC50 |
1960.0 |
nM |
10.1016/j.bmc.2017.06.049 |
| Chikungunya virus |
Chikungunya virus |
EC50 |
2960.0 |
nM |
10.1016/j.bmc.2017.06.049 |
| Chikungunya virus |
Chikungunya virus |
EC50 |
3010.0 |
nM |
10.1016/j.bmc.2017.06.049 |
| Chikungunya virus |
Chikungunya virus |
EC50 |
4950.0 |
nM |
10.1016/j.bmc.2017.06.049 |
| Chlorocebus sabaeus |
Vero |
CC50 |
833000.0 |
nM |
10.1016/j.bmc.2014.01.029 |
| Chlorocebus sabaeus |
Vero |
CC50 |
833000.0 |
nM |
10.1016/j.bmc.2015.02.059 |
| Chlorocebus sabaeus |
Vero |
CC50 |
833000.0 |
nM |
10.1016/j.bmcl.2011.02.100 |
| Chlorocebus sabaeus |
Vero |
CC50 |
833000.0 |
nM |
10.1016/j.bmcl.2017.05.071 |
| Chlorocebus sabaeus |
Vero |
IC50 |
10740.0 |
nM |
10.1016/j.bmc.2013.05.036 |
| Chlorocebus sabaeus |
Vero C1008 |
AUC cytotoxicity |
238.4 |
None |
10.1038/s41586-020-2286-9 |
| Chlorocebus sabaeus |
Vero C1008 |
CC50 |
35500.0 |
nM |
10.1021/acs.jmedchem.0c00626 |
| Chlorocebus sabaeus |
Vero C1008 |
pCC50 |
4.7 |
None |
10.1038/s41586-020-2286-9 |
| Clostridioides difficile |
Clostridioides difficile |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridioides difficile |
Clostridioides difficile |
MIC |
39100.0 |
nM |
10.1016/j.bmcl.2010.04.126 |
| Clostridioides difficile |
Clostridioides difficile |
MIC50 |
0.06 |
ug.mL-1 |
10.1128/aac.01623-06 |
| Clostridioides difficile |
Clostridioides difficile |
MIC50 |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridioides difficile |
Clostridioides difficile |
MIC90 |
0.125 |
ug.mL-1 |
10.1128/aac.01623-06 |
| Clostridioides difficile |
Clostridioides difficile |
MIC90 |
0.5 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium acetobutylicum |
Clostridium acetobutylicum |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium acetobutylicum |
Clostridium acetobutylicum |
MIC50 |
0.5 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium acetobutylicum |
Clostridium acetobutylicum |
MIC90 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium beijerinckii |
Clostridium beijerinckii |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium beijerinckii |
Clostridium beijerinckii |
MIC50 |
0.5 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium beijerinckii |
Clostridium beijerinckii |
MIC90 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium butyricum |
Clostridium butyricum |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium butyricum |
Clostridium butyricum |
MIC50 |
0.5 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium butyricum |
Clostridium butyricum |
MIC90 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium cadaveris |
Clostridium cadaveris |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium cadaveris |
Clostridium cadaveris |
MIC50 |
0.5 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium cadaveris |
Clostridium cadaveris |
MIC90 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| [Clostridium] innocuum |
[Clostridium] innocuum |
MIC |
0.5 |
ug.mL-1 |
10.1128/aac.00441-08 |
| [Clostridium] innocuum |
[Clostridium] innocuum |
MIC50 |
1.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| [Clostridium] innocuum |
[Clostridium] innocuum |
MIC90 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium paraputrificum |
Clostridium paraputrificum |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium paraputrificum |
Clostridium paraputrificum |
MIC50 |
0.5 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium paraputrificum |
Clostridium paraputrificum |
MIC90 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium perfringens |
Clostridium perfringens |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium perfringens |
Clostridium perfringens |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium perfringens |
Clostridium perfringens |
MIC90 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium perfringens (strain SM101 / Type A) |
Pyruvate-flavodoxin oxidoreductase |
Activity |
56.5 |
nmol/mg/min |
10.1128/aac.01159-06 |
| Clostridium septicum |
Clostridium septicum |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium septicum |
Clostridium septicum |
MIC50 |
0.5 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium septicum |
Clostridium septicum |
MIC90 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium sporogenes |
Clostridium sporogenes |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium sporogenes |
Clostridium sporogenes |
MIC50 |
0.5 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium sporogenes |
Clostridium sporogenes |
MIC90 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium tertium |
Clostridium tertium |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium tertium |
Clostridium tertium |
MIC50 |
0.5 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Clostridium tertium |
Clostridium tertium |
MIC90 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Collinsella aerofaciens |
Collinsella aerofaciens |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Collinsella aerofaciens |
Collinsella aerofaciens |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Collinsella aerofaciens |
Collinsella aerofaciens |
MIC90 |
32.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Cryptococcus neoformans |
Cryptococcus neoformans |
Inhibition |
17.15 |
% |
10.6019/CHEMBL4513149 |
| Cryptococcus neoformans |
Cryptococcus neoformans |
MIC |
10000.0 |
nM |
10.6019/CHEMBL4513141 |
| Cryptococcus neoformans |
Cryptococcus neoformans |
MIC |
20000.0 |
nM |
10.6019/CHEMBL4513161 |
| Cryptosporidium |
Cryptosporidium |
MIC |
10.0 |
ug.mL-1 |
10.1021/jm9010719 |
| Cryptosporidium parvum |
Cryptosporidium parvum |
Activity |
5.0 |
% |
10.1128/aac.00207-08 |
| Cryptosporidium parvum |
Cryptosporidium parvum |
Activity |
nan |
None |
10.1021/acs.jmedchem.1c01136 |
| Cryptosporidium parvum |
Cryptosporidium parvum |
Activity |
nan |
None |
10.1128/aac.00207-08 |
| Cryptosporidium parvum |
Cryptosporidium parvum |
EC50 |
2000.0 |
nM |
10.1021/acs.jmedchem.1c01136 |
| Cryptosporidium parvum |
Cryptosporidium parvum |
EC50 |
2300.0 |
nM |
10.1021/acs.jnatprod.7b00850 |
| Cryptosporidium parvum |
Cryptosporidium parvum |
EC50 |
2900.0 |
nM |
10.1021/acs.jnatprod.7b00850 |
| Cryptosporidium parvum |
Cryptosporidium parvum |
EC50 |
3700.0 |
nM |
10.1016/j.bmc.2023.117295 |
| Cryptosporidium parvum |
Cryptosporidium parvum |
IC50 |
1.2 |
ug.mL-1 |
10.1128/aac.00614-09 |
| Cryptosporidium parvum |
Cryptosporidium parvum |
IC50 |
10.0 |
ug.mL-1 |
10.1128/aac.00614-09 |
| Cryptosporidium parvum |
Cryptosporidium parvum |
IC50 |
3250.0 |
nM |
10.1021/jm050973f |
| Cryptosporidium parvum |
Cryptosporidium parvum |
IC50 |
3800.0 |
nM |
10.1128/aac.00207-08 |
| Cutibacterium acnes |
Cutibacterium acnes |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Cutibacterium acnes |
Cutibacterium acnes |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Cutibacterium acnes |
Cutibacterium acnes |
MIC90 |
32.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Echinococcus multilocularis |
Echinococcus multilocularis |
Activity |
nan |
None |
10.1128/aac.00378-07 |
| Eggerthella lenta |
Eggerthella lenta |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Eggerthella lenta |
Eggerthella lenta |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Eggerthella lenta |
Eggerthella lenta |
MIC90 |
32.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Entamoeba histolytica |
Entamoeba histolytica |
IC50 |
504.0 |
nM |
10.1016/j.bmcl.2011.02.100 |
| Entamoeba histolytica |
Entamoeba histolytica |
IC50 |
3900.0 |
nM |
10.1016/j.bmc.2013.05.036 |
| Enterocloster clostridioformis |
Enterocloster clostridioformis |
MIC50 |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Enterocloster clostridioformis |
Enterocloster clostridioformis |
MIC90 |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Escherichia coli |
Escherichia coli |
Inhibition |
-2.79 |
% |
10.6019/CHEMBL4513149 |
| Escherichia coli |
Escherichia coli |
Inhibition |
35.0 |
% |
10.1128/aac.01159-06 |
| Escherichia coli |
Escherichia coli |
MIC |
32.0 |
ug.mL-1 |
10.1128/aac.01159-06 |
| Escherichia coli |
Escherichia coli |
MIC |
10000.0 |
nM |
10.6019/CHEMBL4513141 |
| Escherichia coli |
Escherichia coli |
MIC |
20000.0 |
nM |
10.6019/CHEMBL4513161 |
| Eubacterium limosum |
Eubacterium limosum |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Eubacterium limosum |
Eubacterium limosum |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Eubacterium limosum |
Eubacterium limosum |
MIC90 |
32.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Finegoldia magna |
Finegoldia magna |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Finegoldia magna |
Finegoldia magna |
MIC50 |
0.5 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Finegoldia magna |
Finegoldia magna |
MIC90 |
1.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Fusobacterium mortiferum |
Fusobacterium mortiferum |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Fusobacterium mortiferum |
Fusobacterium mortiferum |
MIC50 |
1.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Fusobacterium mortiferum |
Fusobacterium mortiferum |
MIC90 |
8.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Fusobacterium necrophorum |
Fusobacterium necrophorum |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Fusobacterium necrophorum |
Fusobacterium necrophorum |
MIC50 |
1.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Fusobacterium necrophorum |
Fusobacterium necrophorum |
MIC90 |
8.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Fusobacterium nucleatum |
Fusobacterium nucleatum |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Fusobacterium nucleatum |
Fusobacterium nucleatum |
MIC50 |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Fusobacterium nucleatum |
Fusobacterium nucleatum |
MIC90 |
0.5 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Fusobacterium sp. |
Fusobacterium sp. |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Fusobacterium sp. |
Fusobacterium sp. |
MIC50 |
1.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Fusobacterium sp. |
Fusobacterium sp. |
MIC90 |
8.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Fusobacterium varium |
Fusobacterium varium |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Fusobacterium varium |
Fusobacterium varium |
MIC50 |
1.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Fusobacterium varium |
Fusobacterium varium |
MIC90 |
8.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Giardia |
Giardia |
IC50 |
2.5 |
ug.mL-1 |
10.1021/jm9010719 |
| Giardia intestinalis |
Giardia intestinalis |
Activity |
nan |
None |
10.1128/aac.01548-06 |
| Giardia intestinalis |
Giardia intestinalis |
ED50 |
1.101 |
mg.kg-1 |
10.1016/j.bmcl.2017.05.071 |
| Giardia intestinalis |
Giardia intestinalis |
ED50 |
3.583 |
umol.kg-1 |
10.1016/j.bmcl.2017.05.071 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
15.0 |
nM |
10.1016/j.ejmech.2020.113110 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
17.0 |
nM |
10.1016/j.ejmech.2020.113110 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
18.0 |
nM |
10.1016/j.ejmech.2020.113110 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
21.0 |
nM |
10.1016/j.ejmech.2020.113110 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
1214.0 |
nM |
10.1016/j.bmc.2014.01.029 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
1214.0 |
nM |
10.1016/j.bmc.2015.02.059 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
1214.0 |
nM |
10.1016/j.bmcl.2011.02.100 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
1214.0 |
nM |
10.1016/j.bmcl.2017.05.071 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
1230.27 |
nM |
10.1016/j.bmc.2014.01.029 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
1230.27 |
nM |
10.1016/j.bmc.2015.02.059 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
1973.0 |
nM |
10.1016/j.ejmech.2020.113110 |
| Giardia intestinalis |
Putative fructose-1,6-bisphosphate aldolase |
Potency |
14091.9 |
nM |
None |
| Helicobacter pylori |
Helicobacter pylori |
MIC |
13000.0 |
nM |
10.1016/j.bmcl.2010.04.126 |
| Hepacivirus hominis |
Hepatitis C virus |
EC50 |
130.0 |
nM |
10.1128/aac.00078-08 |
| Hepacivirus hominis |
Hepatitis C virus |
EC50 |
160.0 |
nM |
10.1128/aac.00078-08 |
| Hepacivirus hominis |
Hepatitis C virus |
EC50 |
210.0 |
nM |
10.1021/jm201264t |
| Hepacivirus hominis |
Hepatitis C virus |
EC50 |
330.0 |
nM |
10.1021/jm201264t |
| Hepacivirus hominis |
Hepatitis C virus |
EC50 |
1200.0 |
nM |
10.1128/aac.00078-08 |
| Hepacivirus hominis |
Hepatitis C virus |
EC50 |
1500.0 |
nM |
10.1128/aac.00078-08 |
| Hepacivirus hominis |
Hepatitis C virus |
EC90 |
0.93 |
uM |
10.1021/jm201264t |
| Hepacivirus hominis |
Hepatitis C virus |
EC90 |
1.1 |
uM |
10.1021/jm201264t |
| Hepacivirus hominis |
Hepatitis C virus |
EC90 |
1.2 |
uM |
10.1128/aac.00078-08 |
| Hepacivirus hominis |
Hepatitis C virus |
EC90 |
17.0 |
uM |
10.1128/aac.00078-08 |
| Hepacivirus hominis |
Hepatitis C virus |
EC90 |
26.0 |
uM |
10.1128/aac.00078-08 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
120.0 |
nM |
10.1016/j.ejmech.2014.01.046 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
120.0 |
nM |
10.1021/jm200153p |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
120.0 |
nM |
10.1039/C4MD00521J |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
590.0 |
nM |
10.1021/jm200153p |
| Hepatitis B virus |
Hepatitis B virus |
EC90 |
0.83 |
uM |
10.1021/jm200153p |
| Hepatitis B virus |
Hepatitis B virus |
EC90 |
2.1 |
uM |
10.1021/jm200153p |
| Hepatitis B virus |
Hepatitis B virus |
IC50 |
120.0 |
nM |
10.1021/acs.jmedchem.6b01442 |
| Homo sapiens |
786-0 |
GI50 |
26668.59 |
nM |
None |
| Homo sapiens |
A498 |
GI50 |
56234.13 |
nM |
None |
| Homo sapiens |
A549 |
Activity |
nan |
None |
10.1021/acs.jmedchem.8b01044 |
| Homo sapiens |
A549 |
GI50 |
21978.6 |
nM |
None |
| Homo sapiens |
A549 |
IC50 |
50000.0 |
nM |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
ACHN |
GI50 |
20417.38 |
nM |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
7100.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
8799.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
5000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
9876.4 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Aldose reductase |
IC50 |
8220.0 |
nM |
10.1021/jm500907a |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
8600.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
18999.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
8000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Androgen Receptor |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Androgen Receptor |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Anoctamin-1 |
IC50 |
424.0 |
nM |
10.1016/j.ejmech.2022.114413 |
| Homo sapiens |
Aryl hydrocarbon receptor |
Potency |
707.9 |
nM |
None |
| Homo sapiens |
ASPC1 |
Activity |
nan |
None |
10.1021/acs.jmedchem.8b01044 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
8799.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
7799.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile acid receptor FXR |
Potency |
6309.6 |
nM |
None |
| Homo sapiens |
Bile acid receptor FXR |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Bile salt export pump |
AC50 |
44999.7 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
4900.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bromodomain adjacent to zinc finger domain protein 2B |
Potency |
79432.8 |
nM |
None |
| Homo sapiens |
BT-549 |
GI50 |
14421.15 |
nM |
None |
| Homo sapiens |
Caco-2 |
Activity |
nan |
None |
10.1021/acs.jmedchem.8b01044 |
| Homo sapiens |
Caco-2 |
IC50 |
26800.0 |
nM |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
Caco-2 |
IC50 |
221000.0 |
nM |
10.1016/j.bmcl.2017.05.073 |
| Homo sapiens |
Caco-2 |
Inhibition |
80.0 |
% |
10.1016/j.bmcl.2017.05.073 |
| Homo sapiens |
Caco-2 |
Inhibition |
nan |
% |
10.1016/j.bmcl.2017.05.073 |
| Homo sapiens |
CAKI-1 |
GI50 |
26485.0 |
nM |
None |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
6599.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
COLO 205 |
GI50 |
12705.74 |
nM |
None |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
11.4 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
9526.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Delta opioid receptor |
AC50 |
5000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
DNA polymerase kappa |
Potency |
29934.9 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
14000.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
25000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
7300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
DU-145 |
GI50 |
20137.24 |
nM |
None |
| Homo sapiens |
EKVX |
GI50 |
20989.4 |
nM |
None |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
12000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
1900.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Ferrochelatase, mitochondrial |
Inhibition |
nan |
% |
10.6019/CHEMBL3987221 |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Geminin |
Potency |
13335.9 |
nM |
None |
| Homo sapiens |
Ghrelin receptor |
AC50 |
15000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
HCC 2998 |
GI50 |
13001.7 |
nM |
None |
| Homo sapiens |
HCT-116 |
GI50 |
11168.63 |
nM |
None |
| Homo sapiens |
HCT-15 |
GI50 |
19860.95 |
nM |
None |
| Homo sapiens |
HCT-8 |
Activity |
nan |
None |
10.1128/aac.00614-09 |
| Homo sapiens |
HCT-8 |
EC50 |
25000.0 |
nM |
10.1021/acs.jnatprod.7b00850 |
| Homo sapiens |
HEK293 |
CC50 |
8585.0 |
nM |
10.6019/CHEMBL4513161 |
| Homo sapiens |
HEK293 |
CC50 |
10000.0 |
nM |
10.6019/CHEMBL4513141 |
| Homo sapiens |
HEK-293T |
Activity |
nan |
None |
10.1016/j.bmcl.2012.10.060 |
| Homo sapiens |
HEK-293T |
CC50 |
40000.0 |
nM |
10.1021/acs.jnatprod.7b00850 |
| Homo sapiens |
HEK-293T |
Inhibition |
-3.3 |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
HEK-293T |
Inhibition |
24.4 |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
HeLa |
Activity |
0.02 |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
HeLa |
Activity |
0.04 |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
HeLa |
Activity |
0.06 |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
HeLa |
Activity |
2.34 |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
HeLa |
Activity |
4.49 |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
HeLa |
Activity |
5.32 |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
HeLa |
Activity |
6.6 |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
HeLa |
Activity |
7.48 |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
HeLa |
Activity |
8.27 |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
HeLa |
Activity |
9.59 |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
HeLa |
Activity |
11.4 |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
HeLa |
Activity |
15.12 |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
HeLa |
Activity |
21.84 |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
HeLa |
Activity |
22.76 |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
HeLa |
Activity |
28.45 |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
HeLa |
Activity |
61.96 |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
HeLa |
Activity |
69.88 |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
HeLa |
Activity |
70.64 |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
HeLa |
Activity |
77.33 |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
HeLa |
Activity |
84.07 |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
HeLa |
Activity |
92.32 |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
HeLa |
IC50 |
35000.0 |
nM |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
HeLa |
Inhibition |
19.4 |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
HepG2 |
CC50 |
40000.0 |
nM |
10.1021/acs.jnatprod.7b00850 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HET-1A |
Activity |
nan |
None |
10.1021/acs.jmedchem.8b01044 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone acetyltransferase GCN5 |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Histone deacetylase 6 |
IC50 |
1011.0 |
nM |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
98.28 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
102.97 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
109.78 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
HL-60 |
IC50 |
20100.0 |
nM |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
0.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
F |
30.0 |
% |
10.1016/j.ejmech.2016.09.080 |
| Homo sapiens |
HOP-62 |
GI50 |
22284.35 |
nM |
None |
| Homo sapiens |
HOP-92 |
GI50 |
3221.07 |
nM |
None |
| Homo sapiens |
Hs-578T |
GI50 |
9204.5 |
nM |
None |
| Homo sapiens |
HT-29 |
GI50 |
15488.17 |
nM |
None |
| Homo sapiens |
HT-29 |
IC50 |
50000.0 |
nM |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
Huntingtin |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
IGROV-1 |
GI50 |
16292.96 |
nM |
None |
| Homo sapiens |
K562 |
GI50 |
55718.57 |
nM |
None |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
KM12 |
GI50 |
21978.6 |
nM |
None |
| Homo sapiens |
LOX IMVI |
GI50 |
21827.3 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
M14 |
GI50 |
15885.47 |
nM |
None |
| Homo sapiens |
Malme-3M |
GI50 |
11142.95 |
nM |
None |
| Homo sapiens |
MAP kinase ERK2 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
MCF7 |
GI50 |
10185.91 |
nM |
None |
| Homo sapiens |
MDA-MB-231 |
GI50 |
21827.3 |
nM |
None |
| Homo sapiens |
MDA-MB-435 |
GI50 |
22750.97 |
nM |
None |
| Homo sapiens |
MDA-N |
GI50 |
27289.78 |
nM |
None |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
14000.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
microRNA 21 |
Potency |
414.0 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
MOLT-4 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
7500.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
12999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
4333.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
1400.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
12999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscleblind-like protein 1 |
Potency |
8912.5 |
nM |
None |
| Homo sapiens |
NCI/ADR-RES |
GI50 |
10327.61 |
nM |
None |
| Homo sapiens |
NCI-H226 |
GI50 |
8830.8 |
nM |
None |
| Homo sapiens |
NCI-H23 |
GI50 |
9727.47 |
nM |
None |
| Homo sapiens |
NCI-H322M |
GI50 |
18706.82 |
nM |
None |
| Homo sapiens |
NCI-H460 |
GI50 |
17060.82 |
nM |
None |
| Homo sapiens |
NCI-H522 |
GI50 |
2857.59 |
nM |
None |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
8799.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide S receptor |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
17000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Niemann-Pick C1 protein |
Potency |
501.2 |
nM |
None |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
5100.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
18833.6 |
nM |
None |
| Homo sapiens |
Nuclear receptor ROR-gamma |
Potency |
4216.3 |
nM |
None |
| Homo sapiens |
OVCAR-3 |
GI50 |
5714.79 |
nM |
None |
| Homo sapiens |
OVCAR-4 |
GI50 |
28707.81 |
nM |
None |
| Homo sapiens |
OVCAR-5 |
GI50 |
29853.83 |
nM |
None |
| Homo sapiens |
OVCAR-8 |
GI50 |
15667.51 |
nM |
None |
| Homo sapiens |
PC-3 |
Activity |
nan |
None |
10.1021/acs.jmedchem.8b01044 |
| Homo sapiens |
PC-3 |
GI50 |
9527.96 |
nM |
None |
| Homo sapiens |
PC-3 |
IC50 |
44700.0 |
nM |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
Peroxisome proliferator-activated receptor delta |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Plasma |
PPB |
95.0 |
% |
10.1021/jm200153p |
| Homo sapiens |
Plasma |
T1/2 |
0.1 |
hr |
10.1021/jm200153p |
| Homo sapiens |
Porphobilinogen deaminase |
Inhibition |
nan |
% |
10.6019/CHEMBL3987221 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
18999.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Prelamin-A/C |
Potency |
8912.5 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pyruvate kinase isozymes M1/M2 |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Ras-related protein Rab-9A |
Potency |
501.2 |
nM |
None |
| Homo sapiens |
Retinoid X receptor alpha |
Potency |
8912.5 |
nM |
None |
| Homo sapiens |
RPMI-8226 |
GI50 |
10327.61 |
nM |
None |
| Homo sapiens |
RXF 393 |
GI50 |
4415.7 |
nM |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
15000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
17000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
450.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
3100.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
6300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
SF-268 |
GI50 |
14859.36 |
nM |
None |
| Homo sapiens |
SF-295 |
GI50 |
9908.32 |
nM |
None |
| Homo sapiens |
SF-539 |
GI50 |
24831.33 |
nM |
None |
| Homo sapiens |
Signal transducer and activator of transcription 3 |
Activity |
nan |
None |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
Signal transducer and activator of transcription 3 |
IC50 |
9800.0 |
nM |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
Signal transducer and activator of transcription 3 |
IC50 |
9980.0 |
nM |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
Signal transducer and activator of transcription 3 |
Inhibition |
54.6 |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
Signal transducer and activator of transcription 3 |
Inhibition |
nan |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
Signal transducer and activator of transcription 5A |
Inhibition |
nan |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
SK-MEL-2 |
GI50 |
16330.52 |
nM |
None |
| Homo sapiens |
SK-MEL-28 |
GI50 |
11587.77 |
nM |
None |
| Homo sapiens |
SK-MEL-5 |
GI50 |
11939.88 |
nM |
None |
| Homo sapiens |
SK-OV-3 |
GI50 |
14655.48 |
nM |
None |
| Homo sapiens |
SN12C |
GI50 |
19815.27 |
nM |
None |
| Homo sapiens |
SNB-19 |
GI50 |
17864.88 |
nM |
None |
| Homo sapiens |
SNB-75 |
GI50 |
10162.49 |
nM |
None |
| Homo sapiens |
Survival motor neuron protein |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
SW-620 |
GI50 |
33113.11 |
nM |
None |
| Homo sapiens |
T47D |
GI50 |
13708.82 |
nM |
None |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
5000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
5011.9 |
nM |
None |
| Homo sapiens |
TK-10 |
GI50 |
16069.41 |
nM |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
5600.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosine-protein kinase JAK2 |
Inhibition |
nan |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
Tyrosine-protein kinase SRC |
Inhibition |
nan |
% |
10.1021/acsmedchemlett.0c00544 |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
9441.1 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
21136.0 |
nM |
None |
| Homo sapiens |
U-251 |
GI50 |
19408.86 |
nM |
None |
| Homo sapiens |
U2OS |
CC50 |
25000.0 |
nM |
10.1016/j.bmc.2017.06.049 |
| Homo sapiens |
UACC-257 |
GI50 |
17218.69 |
nM |
None |
| Homo sapiens |
UACC-62 |
GI50 |
4325.14 |
nM |
None |
| Homo sapiens |
UO-31 |
GI50 |
26001.6 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
17000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
14000.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vitamin D receptor |
Potency |
35481.3 |
nM |
None |
| Hoylesella loescheii |
Hoylesella loescheii |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Hoylesella loescheii |
Hoylesella loescheii |
MIC50 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Hoylesella loescheii |
Hoylesella loescheii |
MIC90 |
8.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Inhibition |
13.55 |
% |
10.6019/CHEMBL4513149 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
MIC |
10000.0 |
nM |
10.6019/CHEMBL4513141 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
MIC |
20000.0 |
nM |
10.6019/CHEMBL4513161 |
| Lacticaseibacillus rhamnosus |
Lacticaseibacillus rhamnosus |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Lacticaseibacillus rhamnosus |
Lacticaseibacillus rhamnosus |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Lacticaseibacillus rhamnosus |
Lacticaseibacillus rhamnosus |
MIC90 |
32.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Lactiplantibacillus plantarum |
Lactiplantibacillus plantarum |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Lactiplantibacillus plantarum |
Lactiplantibacillus plantarum |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Lactiplantibacillus plantarum |
Lactiplantibacillus plantarum |
MIC90 |
32.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Lactobacillus acidophilus |
Lactobacillus acidophilus |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Lactobacillus acidophilus |
Lactobacillus acidophilus |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Lactobacillus acidophilus |
Lactobacillus acidophilus |
MIC90 |
32.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Lactobacillus jensenii |
Lactobacillus jensenii |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Lactobacillus jensenii |
Lactobacillus jensenii |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Lactobacillus jensenii |
Lactobacillus jensenii |
MIC90 |
32.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Lactobacillus sp. |
Lactobacillus sp. |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Lactobacillus sp. |
Lactobacillus sp. |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Lactobacillus sp. |
Lactobacillus sp. |
MIC90 |
32.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Leishmania amazonensis |
Leishmania amazonensis |
IC50 |
7230.0 |
nM |
10.1016/j.bmc.2014.01.029 |
| Leishmania amazonensis |
Leishmania amazonensis |
IC50 |
7230.0 |
nM |
10.1016/j.bmcl.2017.05.071 |
| Leishmania amazonensis |
Leishmania amazonensis |
Ratio IC50 |
2.0 |
None |
10.1016/j.bmc.2014.01.029 |
| Leishmania mexicana |
Leishmania mexicana |
IC50 |
6180.0 |
nM |
10.1016/j.bmcl.2011.02.100 |
| Leishmania mexicana |
Leishmania mexicana |
IC50 |
6180.0 |
nM |
10.1016/j.bmcl.2017.05.071 |
| Leishmania mexicana |
Pyruvate kinase |
Potency |
12589.3 |
nM |
None |
| Limosilactobacillus fermentum |
Limosilactobacillus fermentum |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Limosilactobacillus fermentum |
Limosilactobacillus fermentum |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Limosilactobacillus fermentum |
Limosilactobacillus fermentum |
MIC90 |
32.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Limosilactobacillus reuteri |
Limosilactobacillus reuteri |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Limosilactobacillus reuteri |
Limosilactobacillus reuteri |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Limosilactobacillus reuteri |
Limosilactobacillus reuteri |
MIC90 |
32.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Meriones unguiculatus |
Meriones unguiculatus |
Activity |
14.0 |
% |
10.1021/jm050973f |
| Meriones unguiculatus |
Meriones unguiculatus |
Activity |
55.0 |
% |
10.1021/jm050973f |
| Mesocricetus auratus |
BHK-21 |
CC50 |
25000.0 |
nM |
10.1016/j.bmc.2017.06.049 |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
2818.4 |
nM |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
19952.6 |
nM |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
35481.3 |
nM |
None |
| Mus musculus |
Peritoneal macrophage |
IC50 |
2000000.0 |
nM |
10.1016/j.bmc.2020.115757 |
| Mus musculus |
RAW264.7 |
IC50 |
1540000.0 |
nM |
10.1016/j.bmc.2020.115757 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Activity |
1.0 |
None |
10.1021/jm9010719 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Activity |
2.0 |
None |
10.1021/jm9010719 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Activity |
3.5 |
None |
10.1021/jm9010719 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Activity |
5.0 |
None |
10.1021/jm9010719 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Activity |
6.0 |
None |
10.1021/jm9010719 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Activity |
nan |
None |
10.1021/jm9010719 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Activity |
nan |
None |
10.1021/ml200157f |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
1.0 |
ug.mL-1 |
10.1021/jm9010719 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
1.0 |
ug.mL-1 |
10.1021/ml200157f |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
16.0 |
ug.mL-1 |
10.1021/jm9010719 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
10000.0 |
nM |
10.1016/j.bmc.2022.116938 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
33190.0 |
nM |
10.1016/j.ejmech.2021.114066 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
52120.0 |
nM |
10.1016/j.bmcl.2011.06.076 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
162710.0 |
nM |
10.1016/j.bmcl.2012.10.060 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
nan |
None |
10.1016/j.bmcl.2011.06.076 |
| Mycobacterium tuberculosis |
Trehalose-binding lipoprotein LpqY |
Kd |
85400.0 |
nM |
10.1039/d2md00104g |
| Mycobacterium tuberculosis H37Rv |
Mycobacterium tuberculosis H37Rv |
Drug metabolism |
nan |
None |
10.1021/ml200157f |
| Mycobacterium tuberculosis H37Rv |
Mycobacterium tuberculosis H37Rv |
Drug uptake |
nan |
None |
10.1021/ml200157f |
| Naegleria gruberi |
Naegleria gruberi |
Inhibition |
62.7 |
% |
10.6019/CHEMBL4513101 |
| Paeniclostridium sordellii |
Paeniclostridium sordellii |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Paeniclostridium sordellii |
Paeniclostridium sordellii |
MIC50 |
0.5 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Paeniclostridium sordellii |
Paeniclostridium sordellii |
MIC90 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Parabacteroides distasonis |
Parabacteroides distasonis |
MIC |
2.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Parabacteroides distasonis |
Parabacteroides distasonis |
MIC50 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Parabacteroides distasonis |
Parabacteroides distasonis |
MIC90 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Parabacteroides merdae |
Parabacteroides merdae |
MIC |
2.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Parabacteroides merdae |
Parabacteroides merdae |
MIC50 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Parabacteroides merdae |
Parabacteroides merdae |
MIC90 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Paraclostridium bifermentans |
Paraclostridium bifermentans |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Paraclostridium bifermentans |
Paraclostridium bifermentans |
MIC50 |
0.5 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Paraclostridium bifermentans |
Paraclostridium bifermentans |
MIC90 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Parvimonas micra |
Parvimonas micra |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Parvimonas micra |
Parvimonas micra |
MIC50 |
0.5 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Parvimonas micra |
Parvimonas micra |
MIC90 |
1.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Peptoniphilus asaccharolyticus |
Peptoniphilus asaccharolyticus |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Peptoniphilus asaccharolyticus |
Peptoniphilus asaccharolyticus |
MIC50 |
0.5 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Peptoniphilus asaccharolyticus |
Peptoniphilus asaccharolyticus |
MIC90 |
1.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Peptostreptococcus anaerobius |
Peptostreptococcus anaerobius |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Peptostreptococcus anaerobius |
Peptostreptococcus anaerobius |
MIC50 |
0.5 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Peptostreptococcus anaerobius |
Peptostreptococcus anaerobius |
MIC90 |
1.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Photinus pyralis |
Luciferin 4-monooxygenase |
Potency |
720.8 |
nM |
None |
| Photinus pyralis |
Luciferin 4-monooxygenase |
Potency |
6745.6 |
nM |
None |
| Plasmodium berghei |
Plasmodium berghei |
IC50 |
3890.0 |
nM |
10.1016/j.bmcl.2011.02.100 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
15101.4 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
19011.5 |
nM |
None |
| Porphyromonas asaccharolytica |
Porphyromonas asaccharolytica |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Porphyromonas asaccharolytica |
Porphyromonas asaccharolytica |
MIC50 |
0.5 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Porphyromonas asaccharolytica |
Porphyromonas asaccharolytica |
MIC90 |
1.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Porphyromonas somerae |
Porphyromonas somerae |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Porphyromonas somerae |
Porphyromonas somerae |
MIC50 |
0.5 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Porphyromonas somerae |
Porphyromonas somerae |
MIC90 |
1.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Prevotella bivia |
Prevotella bivia |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Prevotella bivia |
Prevotella bivia |
MIC50 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Prevotella bivia |
Prevotella bivia |
MIC90 |
8.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Prevotella corporis |
Prevotella corporis |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Prevotella corporis |
Prevotella corporis |
MIC50 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Prevotella corporis |
Prevotella corporis |
MIC90 |
8.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Prevotella disiens |
Prevotella disiens |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Prevotella disiens |
Prevotella disiens |
MIC50 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Prevotella disiens |
Prevotella disiens |
MIC90 |
8.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Prevotella intermedia |
Prevotella intermedia |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Prevotella intermedia |
Prevotella intermedia |
MIC50 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Prevotella intermedia |
Prevotella intermedia |
MIC90 |
8.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Prevotella melaninogenica |
Prevotella melaninogenica |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Prevotella melaninogenica |
Prevotella melaninogenica |
MIC50 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Prevotella melaninogenica |
Prevotella melaninogenica |
MIC90 |
8.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Inhibition |
19.1 |
% |
10.6019/CHEMBL4513149 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
10000.0 |
nM |
10.6019/CHEMBL4513141 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
20000.0 |
nM |
10.6019/CHEMBL4513161 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
3.1 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Nuclear receptor subfamily 1 group I member 2 |
Potency |
44668.4 |
nM |
None |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
454.8 |
nM |
None |
| Rattus norvegicus |
Plasma |
Drug metabolism |
nan |
None |
10.1016/j.ejmech.2016.09.080 |
| Rattus norvegicus |
Rattus norvegicus |
AUC |
2040.0 |
ng.hr.mL-1 |
10.1016/j.ejmech.2016.09.080 |
| Rattus norvegicus |
Rattus norvegicus |
AUC |
6500.0 |
ng.hr.mL-1 |
10.1016/j.ejmech.2016.09.080 |
| Rattus norvegicus |
Rattus norvegicus |
AUC |
14100.0 |
ng.hr.mL-1 |
10.1016/j.ejmech.2016.09.080 |
| Rattus norvegicus |
Rattus norvegicus |
AUC |
15950.0 |
ng.hr.mL-1 |
10.1016/j.ejmech.2016.09.080 |
| Rattus norvegicus |
Rattus norvegicus |
Cmax |
2414.66 |
nM |
10.1016/j.ejmech.2016.09.080 |
| Rattus norvegicus |
Rattus norvegicus |
Cmax |
15034.66 |
nM |
10.1016/j.ejmech.2016.09.080 |
| Rattus norvegicus |
Rattus norvegicus |
Cmax |
35959.52 |
nM |
10.1016/j.ejmech.2016.09.080 |
| Rattus norvegicus |
Rattus norvegicus |
Cmax |
66712.23 |
nM |
10.1016/j.ejmech.2016.09.080 |
| Rattus norvegicus |
Rattus norvegicus |
F |
2.8 |
% |
10.1016/j.ejmech.2016.09.080 |
| Rattus norvegicus |
Rattus norvegicus |
T1/2 |
0.2 |
hr |
10.1016/j.ejmech.2016.09.080 |
| Rattus norvegicus |
Rattus norvegicus |
Tmax |
0.08333 |
hr |
10.1016/j.ejmech.2016.09.080 |
| Rattus norvegicus |
Rattus norvegicus |
Tmax |
0.4 |
hr |
10.1016/j.ejmech.2016.09.080 |
| Rattus norvegicus |
Rattus norvegicus |
Tmax |
0.7 |
hr |
10.1016/j.ejmech.2016.09.080 |
| Rattus norvegicus |
Rattus norvegicus |
Tmax |
1.4 |
hr |
10.1016/j.ejmech.2016.09.080 |
| Rattus norvegicus |
Rattus norvegicus |
Tmax |
2.1 |
hr |
10.1016/j.ejmech.2016.09.080 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Schaalia meyeri |
Schaalia meyeri |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Schaalia meyeri |
Schaalia meyeri |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Schaalia meyeri |
Schaalia meyeri |
MIC90 |
32.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
11.0 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
100.65 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
AUC |
202.3 |
None |
10.1038/s41586-020-2286-9 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
EC50 |
2120.0 |
nM |
10.1021/acs.jmedchem.0c00626 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.4584 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
2818.38 |
nM |
10.1038/s41586-020-2286-9 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
82700.0 |
nM |
10.1021/acs.jnatprod.2c00580 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.07 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.78 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
43.61 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.6122 |
None |
10.1101/2020.04.03.023846 |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
50.75 |
% |
10.6019/CHEMBL4513149 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
10000.0 |
nM |
10.6019/CHEMBL4513141 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
20000.0 |
nM |
10.6019/CHEMBL4513161 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
Activity |
nan |
None |
10.1128/aac.00901-09 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
IC50 |
1.0 |
ug.mL-1 |
10.1128/aac.00901-09 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
Inhibition |
nan |
% |
10.1128/aac.00901-09 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
MIC |
8.0 |
ug.mL-1 |
10.1128/aac.00901-09 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
MIC |
16.0 |
ug.mL-1 |
10.1128/aac.00901-09 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
MIC |
32.0 |
ug.mL-1 |
10.1128/aac.00901-09 |
| Staphylococcus haemolyticus |
Staphylococcus haemolyticus |
Activity |
nan |
None |
10.1128/aac.00901-09 |
| Staphylococcus hominis |
Staphylococcus hominis |
MIC |
32.0 |
ug.mL-1 |
10.1128/aac.00901-09 |
| Thomasclavelia ramosa |
Thomasclavelia ramosa |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Thomasclavelia ramosa |
Thomasclavelia ramosa |
MIC50 |
0.5 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Thomasclavelia ramosa |
Thomasclavelia ramosa |
MIC90 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| Trichomonas vaginalis |
Trichomonas vaginalis |
IC50 |
68.0 |
nM |
10.1016/j.bmc.2014.01.029 |
| Trichomonas vaginalis |
Trichomonas vaginalis |
IC50 |
68.0 |
nM |
10.1016/j.bmc.2015.02.059 |
| Trichomonas vaginalis |
Trichomonas vaginalis |
IC50 |
68.0 |
nM |
10.1016/j.bmcl.2011.02.100 |
| Trichomonas vaginalis |
Trichomonas vaginalis |
IC50 |
68.0 |
nM |
10.1016/j.bmcl.2017.05.071 |
| Trichomonas vaginalis |
Trichomonas vaginalis |
IC50 |
79.43 |
nM |
10.1016/j.bmc.2014.01.029 |
| Trypanosoma brucei brucei (strain 927/4 GUTat10.1) |
Putative uncharacterized protein |
Potency |
2818.4 |
nM |
None |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
18730.0 |
nM |
10.1016/j.bmc.2014.01.029 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
18730.0 |
nM |
10.1016/j.bmcl.2011.02.100 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
18730.0 |
nM |
10.1016/j.bmcl.2017.05.071 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
Ratio IC50 |
2.0 |
None |
10.1016/j.bmc.2014.01.029 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
Ratio IC50 |
2.0 |
None |
10.1016/j.bmcl.2017.05.071 |
| None |
ADMET |
AUC |
3200.0 |
ng.hr.mL-1 |
10.1021/acsmedchemlett.0c00544 |
| None |
ADMET |
AUC |
11200.0 |
ng.hr.mL-1 |
10.1021/acsmedchemlett.0c00544 |
| None |
ADMET |
AUC Ratio |
1.178 |
None |
10.1038/s41586-020-2286-9 |
| None |
ADMET |
CC50 |
35000.0 |
nM |
10.1021/jm201264t |
| None |
ADMET |
CC50 |
38000.0 |
nM |
10.1128/aac.00078-08 |
| None |
ADMET |
CC50 |
49000.0 |
nM |
10.1021/jm201264t |
| None |
ADMET |
CC50 |
68000.0 |
nM |
10.1128/aac.00078-08 |
| None |
ADMET |
CC50 |
97000.0 |
nM |
10.1128/aac.00078-08 |
| None |
ADMET |
CC50 |
100000.0 |
nM |
10.1021/jm200153p |
| None |
ADMET |
CL |
8.333 |
mL.min-1.kg-1 |
10.1021/acsmedchemlett.0c00544 |
| None |
ADMET |
CL |
105.0 |
mL.min-1.kg-1 |
10.1021/acsmedchemlett.0c00544 |
| None |
ADMET |
Cmax |
3254.25 |
nM |
10.1021/acsmedchemlett.0c00544 |
| None |
ADMET |
Cmax |
9111.91 |
nM |
10.1021/acsmedchemlett.0c00544 |
| None |
ADMET |
Drugexcretion |
33.0 |
% |
10.1016/j.ejmech.2016.09.080 |
| None |
ADMET |
Drugexcretion |
64.0 |
% |
10.1016/j.ejmech.2016.09.080 |
| None |
ADMET |
F |
5.7 |
% |
10.1021/acsmedchemlett.0c00544 |
| None |
ADMET |
T1/2 |
0.05 |
hr |
10.1021/acsmedchemlett.0c00544 |
| None |
ADMET |
T1/2 |
0.3 |
hr |
10.1021/acsmedchemlett.0c00544 |
| None |
ADMET |
T1/2 |
0.6 |
hr |
10.1021/acsmedchemlett.0c00544 |
| None |
ADMET |
T1/2 |
0.8 |
hr |
10.1021/acsmedchemlett.0c00544 |
| None |
ADMET |
Tmax |
2.0 |
hr |
10.1021/acsmedchemlett.0c00544 |
| None |
ADMET |
Vd/F |
0.08 |
L.kg-1 |
10.1021/acsmedchemlett.0c00544 |
| None |
Erythrocyte |
HC10 |
20.0 |
uM |
10.6019/CHEMBL4513161 |
| None |
Molecular identity unknown |
Potency |
199.5 |
nM |
None |
| None |
Molecular identity unknown |
Potency |
5955.7 |
nM |
None |
| None |
Molecular identity unknown |
Potency |
35481.3 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Activity |
nan |
None |
10.1128/aac.00553-08 |
| None |
NON-PROTEIN TARGET |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| None |
NON-PROTEIN TARGET |
MIC |
1.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| None |
NON-PROTEIN TARGET |
MIC |
2.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| None |
NON-PROTEIN TARGET |
MIC50 |
0.25 |
ug.mL-1 |
10.1128/aac.00441-08 |
| None |
NON-PROTEIN TARGET |
MIC50 |
0.5 |
ug.mL-1 |
10.1128/aac.00441-08 |
| None |
NON-PROTEIN TARGET |
MIC50 |
1.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| None |
NON-PROTEIN TARGET |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| None |
NON-PROTEIN TARGET |
MIC50 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| None |
NON-PROTEIN TARGET |
MIC90 |
0.5 |
ug.mL-1 |
10.1128/aac.00441-08 |
| None |
NON-PROTEIN TARGET |
MIC90 |
1.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| None |
NON-PROTEIN TARGET |
MIC90 |
4.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| None |
NON-PROTEIN TARGET |
MIC90 |
32.0 |
ug.mL-1 |
10.1128/aac.00441-08 |
| None |
Unchecked |
Ac50 |
1.0 |
uM |
None |
| None |
Unchecked |
Ac50 |
22.39 |
uM |
None |
| None |
Unchecked |
Ac50 |
25.12 |
uM |
None |
| None |
Unchecked |
Ac50 |
28.18 |
uM |
None |
| None |
Unchecked |
Ac50 |
31.62 |
uM |
None |
| None |
Unchecked |
AC50 |
1000.0 |
nM |
None |
| None |
Unchecked |
AC50 |
22387.2 |
nM |
None |
| None |
Unchecked |
AC50 |
25118.9 |
nM |
None |
| None |
Unchecked |
AC50 |
28183.8 |
nM |
None |
| None |
Unchecked |
AC50 |
31622.8 |
nM |
None |
| None |
Unchecked |
AC50 |
31630.0 |
nM |
None |
| None |
Unchecked |
Activity |
8.5 |
nmol/mg/min |
10.1128/aac.01159-06 |
| None |
Unchecked |
Activity |
18.8 |
nmol/mg/min |
10.1128/aac.01159-06 |
| None |
Unchecked |
Activity |
19.0 |
nmol/mg/min |
10.1128/aac.01159-06 |
| None |
Unchecked |
Activity |
41.5 |
nmol/mg/min |
10.1128/aac.01159-06 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/acsmedchemlett.0c00544 |
| None |
Unchecked |
Activity |
nan |
None |
10.1128/aac.01159-06 |
| None |
Unchecked |
EC50 |
20170.0 |
nM |
None |
| None |
Unchecked |
IC50 |
0.3 |
ug.mL-1 |
10.1016/j.bmc.2020.115757 |
| None |
Unchecked |
IC50 |
2061.2 |
nM |
None |
| None |
Unchecked |
IC50 |
10000.0 |
nM |
None |
| None |
Unchecked |
IC50 |
30000.0 |
nM |
10.1021/acsmedchemlett.0c00544 |
| None |
Unchecked |
IC50 |
31800.0 |
nM |
10.1021/acsmedchemlett.0c00544 |
| None |
Unchecked |
IC50 |
91960.0 |
nM |
None |
| None |
Unchecked |
IC50 |
148621.0 |
nM |
None |
| None |
Unchecked |
IC50 |
150000.0 |
nM |
None |
| None |
Unchecked |
Inhibition |
22.0 |
% |
10.1128/aac.01159-06 |
| None |
Unchecked |
Inhibition |
31.0 |
% |
10.1016/j.bmc.2015.02.059 |
| None |
Unchecked |
Inhibition |
54.0 |
% |
10.1016/j.bmcl.2010.04.126 |
| None |
Unchecked |
Inhibition |
75.0 |
% |
10.1128/aac.01548-06 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1016/j.bmcl.2014.01.014 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1021/acsmedchemlett.0c00544 |
| None |
Unchecked |
Ki |
300.0 |
nM |
10.1128/aac.01548-06 |
| None |
Unchecked |
Ki |
2200.0 |
nM |
10.1128/aac.01159-06 |
| None |
Unchecked |
Ki |
4500.0 |
nM |
10.1128/aac.01159-06 |
| None |
Unchecked |
Ki |
10000.0 |
nM |
10.1128/aac.01159-06 |
| None |
Unchecked |
Km |
44000.0 |
nM |
10.1128/aac.01159-06 |
| None |
Unchecked |
Potency |
100.0 |
nM |
None |
| None |
Unchecked |
Potency |
1995.3 |
nM |
None |
| None |
Unchecked |
Potency |
6682.4 |
nM |
None |
| None |
Unchecked |
Potency |
7497.8 |
nM |
None |
| None |
Unchecked |
Potency |
7943.3 |
nM |
None |
| None |
Unchecked |
Potency |
8912.5 |
nM |
None |
| None |
Unchecked |
Potency |
23109.3 |
nM |
None |
| None |
Unchecked |
Potency |
25118.9 |
nM |
None |
| None |
Unchecked |
Potency |
28695.4 |
nM |
None |
| None |
Unchecked |
Potency |
39810.7 |
nM |
None |
| None |
Unchecked |
Ratio CC50/EC50 |
5.05 |
None |
10.1016/j.bmc.2017.06.049 |
| None |
Unchecked |
Ratio CC50/EC50 |
8.31 |
None |
10.1016/j.bmc.2017.06.049 |
| None |
Unchecked |
Ratio CC50/EC50 |
8.45 |
None |
10.1016/j.bmc.2017.06.049 |
| None |
Unchecked |
Ratio CC50/EC50 |
12.76 |
None |
10.1016/j.bmc.2017.06.049 |
| None |
Unchecked |
Ratio CC50/EC50 |
16.7 |
None |
10.1021/acs.jmedchem.0c00626 |
| None |
Unchecked |
Ratio CC50/EC50 |
57.0 |
None |
10.1128/aac.00078-08 |
| None |
Unchecked |
Ratio CC50/EC50 |
65.0 |
None |
10.1128/aac.00078-08 |
| None |
Unchecked |
Ratio CC50/EC50 |
143.0 |
None |
10.1021/jm201264t |
| None |
Unchecked |
Ratio CC50/EC50 |
149.0 |
None |
10.1021/jm201264t |
| None |
Unchecked |
Ratio CC50/EC50 |
238.0 |
None |
10.1128/aac.00078-08 |
| None |
Unchecked |
Ratio CC50/IC50 |
44.0 |
None |
10.1016/j.bmcl.2011.02.100 |
| None |
Unchecked |
Ratio CC50/IC50 |
115.0 |
None |
10.1016/j.bmcl.2017.05.071 |
| None |
Unchecked |
Ratio CC50/IC50 |
135.0 |
None |
10.1016/j.bmcl.2011.02.100 |
| None |
Unchecked |
Ratio CC50/IC50 |
214.0 |
None |
10.1016/j.bmcl.2011.02.100 |
| None |
Unchecked |
Ratio CC50/IC50 |
686.0 |
None |
10.1016/j.bmc.2014.01.029 |
| None |
Unchecked |
Ratio CC50/IC50 |
686.0 |
None |
10.1016/j.bmcl.2011.02.100 |
| None |
Unchecked |
Ratio CC50/IC50 |
686.0 |
None |
10.1016/j.bmcl.2017.05.071 |
| None |
Unchecked |
Ratio CC50/IC50 |
1653.0 |
None |
10.1016/j.bmcl.2011.02.100 |
| None |
Unchecked |
Ratio CC50/IC50 |
12250.0 |
None |
10.1016/j.bmc.2014.01.029 |
| None |
Unchecked |
Ratio CC50/IC50 |
12250.0 |
None |
10.1016/j.bmcl.2011.02.100 |
| None |
Unchecked |
Ratio CC50/IC50 |
12250.0 |
None |
10.1016/j.bmcl.2017.05.071 |
| None |
Unchecked |
Ratio IC50 |
2.75 |
None |
10.1016/j.bmc.2013.05.036 |
| None |
Unchecked |
Selectivity Index |
2.8 |
None |
10.1021/acsmedchemlett.0c00544 |
| None |
Unchecked |
Selectivity Index |
48.0 |
None |
10.1021/jm200153p |
| None |
Unchecked |
Selectivity Index |
121.0 |
None |
10.1021/jm200153p |
| None |
Unchecked |
T1/2 |
7.3 |
hr |
10.1021/acs.jmedchem.0c00910 |